03 Profile
Hansard to 4 November 2026 · 31,174 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Rare diseases
Professor Leszek Lisowski
Leads the Translational Vectorology Unit at the Children's Medical Research Institute
press citation on 1 topic since 14 May 2026 · last quoted 14 May 2026
02 Quoted on · 1 of 29 topics
Professor Leszek Lisowski: key facts
- Kind of voice
- Academic
- Role
- Leads the Translational Vectorology Unit at the Children's Medical Research Institute
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 14 May 2026
04 The signal · where Professor Leszek Lisowski sits on rare diseases
Ranked 25= of 231 voices quoted in the press on rare diseases, level with 206 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1=Vinay PrasadAcademicProfessor of Epidemiology and Biostatistics and Medicine; hematologist-oncologist, University of California, San Francisco (UCSF)4
- 1=David WeitzAcademicMallinckrodt Professor of Physics and of Applied Physics; Professor of Systems Biology, Harvard University (John A. Paulson School of Engineering and Applied Sciences)4
- 1=Tuomas KnowlesAcademic1920 Professor of Physical Chemistry, University of Cambridge4
- 25=Dr Brian Hon-yin ChungAcademicClinical Associate Professor at The University of Hong Kong and Chief Executive Officer of the Hong Kong Genome Institute1
- 25=Dr Francesco CutraleSector leaderCo-Founder and Chief Technology Officer of Kulia Labs Inc.1
- 25=Professor Leszek LisowskiAcademicLeads the Translational Vectorology Unit at the Children's Medical Research Institute1
- 25=Professor Liang ZicaiSector leaderFounder and Chairman of Suzhou Ribo Life Science1
- 25=Claire BoothAcademicMBBS, PhD, Great Ormond Street Children's Hospital, London1
Showing the leaders and the ranks around 25=, of 231 voices · See every voice on the topic →
05 On the record · press
What Professor Leszek Lisowski has said
- geneonline.com1
Where Professor Leszek Lisowski has been quoted
- 01From Detection to Cure: How Innovations and Collaborations Are Rewriting the Rare Disease Playbookgeneonline.com · 14 May 2026
Verbatim
“Historically, moving a drug from an initial concept to a Phase 1 clinical trial took 10 to 15 years. Nowadays, researchers can advance a new biologic or gene therapy into human studies in about three years”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.